Evidence map›Paper›PMID 34576174›Full record

ArticleInternational journal of molecular sciences2021

Key Physicochemical Determinants in the Antimicrobial Peptide RiLK1 Promote Amphipathic Structures.

Lucia Falcigno, Gabriella D'Auria, Gianna Palmieri, Marta Gogliettino, Bruna Agrillo, Rosarita Tatè, Principia Dardano, Luigi Nicolais, Marco Balestrieri

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Lucia FalcignoDepartment of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy.ORCID 0000-0002-3758-2716
Gabriella D'AuriaDepartment of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy.ORCID 0000-0002-1340-8545
Gianna PalmieriInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), Via Pietro Castellino 111, 80131 Naples, Italy.ORCID 0000-0002-9007-4075
Marta GogliettinoInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), Via Pietro Castellino 111, 80131 Naples, Italy.
Bruna AgrilloInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), Via Pietro Castellino 111, 80131 Naples, Italy.
Rosarita TatèInstitute of Genetics and Biophysics, National Research Council (IGB-CNR), Via Pietro Castellino 111, 80131 Naples, Italy.
Principia DardanoInstitute of Applied Sciences & Intelligent Systems, National Research Council (ISASI-CNR), Via Pietro Castellino 111, 80131 Naples, Italy.ORCID 0000-0002-0616-3914
Luigi NicolaisMaterias Srl, Corso N. Protopisani 70, 80146 Naples, Italy.
Marco BalestrieriInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), Via Pietro Castellino 111, 80131 Naples, Italy.ORCID 0000-0003-4343-2148
Institute of Biosciences and Bioresources · ITUniversity of Naples Federico II · ITInstitute of Genetics and Biophysics · ITNational Research Council · IT

Funding

Ministero della Salute IZS ME 06/18 RCMinistero della Salute IZSME 06/20 RCMinistero dello Sviluppo Economico F/200092/01-03/X45
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) represent a skilled class of new antibiotics, due to their broad range of activity, rapid killing, and low bacterial resistance. Many efforts have been made to discover AMPs with improved performances, i.e., high antimicrobial activity, low cytotoxicity against human cells, stability against proteolytic degradation, and low costs of production. In the design of new AMPs, several physicochemical features, such as hydrophobicity, net positive charge, propensity to assume amphipathic conformation, and self-assembling properties, must be considered. Starting from the sequence of the dodecapeptide 1018-K6, we designed a new 10-aminoacid peptide, namely RiLK1, which is highly effective against both fungi and Gram-positive and -negative bacteria at low micromolar concentrations without causing human cell cytotoxicity. In order to find the structural reasons explaining the improved performance of RiLK1 versus 1018-K6, a comparative analysis of the two peptides was carried out with a combination of CD, NMR, and fluorescence spectroscopies, while their self-assembling properties were analyzed by optical and atomic force microscopies. Interestingly, the different spectroscopic and microscopic profiles exhibited by the two peptides, including the propensity of RiLK1 to adopt helix arrangements in contrast to 1018-K6, could explain the improved bactericidal, antifungal, and anti-biofilm activities shown by the new peptide against a panel of food pathogens.

Indexed as

Gram-Negative BacteriaGram-Positive BacteriaMagnetic Resonance SpectroscopyMicrobial Sensitivity TestsMicroscopy, Atomic ForcePore Forming Cytotoxic ProteinsSpectrometry, FluorescencePore Forming Cytotoxic ProteinsAMPatomic force microscopy (AFM)CDconformation distributionfluorescenceNMRself-assemblingstereomicroscopy

Identifiers

PMID34576174
PMCPMC8472000
OpenAlexW3199775598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.